Terms: = Breast cancer AND WAS, P42768, 7454, ENSG00000015285, WASP, THC, IMD2 AND Clinical Outcome
2 results:
1. Therapeutic targeting of HER2-CB
Blasco-Benito S; Moreno E; Seijo-Vila M; Tundidor I; Andradas C; Caffarel MM; Caro-Villalobos M; Urigüen L; Diez-Alarcia R; Moreno-Bueno G; Hernández L; Manso L; Homar-Ruano P; McCormick PJ; Bibic L; Bernadó-Morales C; Arribas J; Canals M; Casadó V; Canela EI; Guzmán M; Pérez-Gómez E; Sánchez C
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3863-3872. PubMed ID: 30733293
[TBL] [Abstract] [Full Text] [Related]
2. N-wasp is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer.
Martin TA; Pereira G; Watkins G; Mansel RE; Jiang WG
Clin Exp Metastasis; 2008; 25(2):97-108. PubMed ID: 17985201
[TBL] [Abstract] [Full Text] [Related]
